Predictors of Treatment Success After Periprosthetic Joint Infection: 24-Month Follow up From a Multicenter Prospective Observational Cohort Study of 653 Patients
暂无分享,去创建一个
L. Manning | L. B. Solomon | D. Looke | S. McBride | E. Athan | P. Yates | J. Robinson | T. Aung | K. Grimwade | S. Graves | Ben Clark | D. Campbell | C. Aboltins | A. Sud | D. Paterson | Ton Tran | M. Loewenthal | S. Metcalf | C. Lemoh | A. Torda | R. Nelson | A. Reid | C. Luey | R. Chean | Peter Leung | P. Huggan | K. Schneider | Darcie Cooper | B. Rad | T. Allworth | K. Read | V. Nagendra | Nora Mutalima | M. Sehu | Joshua S Davis | Archana Sud | L. Solomon | N. Mutalima | Chris Lemoh | Stephen J. McBride | Renjy Nelson
[1] B. Pijls,et al. Outcome of Debridement, Antibiotics, and Implant Retention for Staphylococcal Hip and Knee Prosthetic Joint Infections, Focused on Rifampicin Use: A Systematic Review and Meta-Analysis , 2021, Open forum infectious diseases.
[2] P. Wretenberg,et al. What Are the Long-term Outcomes of Mortality, Quality of Life, and Hip Function after Prosthetic Joint Infection of the Hip? A 10-year Follow-up from Sweden , 2021, Clinical orthopaedics and related research.
[3] Jacob T. Munro,et al. Success Rates of Debridement, Antibiotics, and Implant Retention in 230 Infected Total Knee Arthroplasties: Implications for Classification of Periprosthetic Joint Infection. , 2020, The Journal of arthroplasty.
[4] L. Manning,et al. Clinical Characteristics, Etiology, and Initial Management Strategy of Newly Diagnosed Periprosthetic Joint Infection: A Multicenter, Prospective Observational Cohort Study of 783 Patients , 2020, Open forum infectious diseases.
[5] R. Burgkart,et al. Peri-Prosthetic Joint Infection of the Knee Causes High Levels of Psychosocial Distress: A Prospective Cohort Study. , 2020, Surgical infections.
[6] W. Figved,et al. Rifampin combination therapy in staphylococcal prosthetic joint infections: a randomized controlled trial , 2020, Journal of Orthopaedic Surgery and Research.
[7] Shi-gui Yan,et al. Debridement, antibiotics, and implant retention for periprosthetic knee infections: a pooling analysis of 1266 cases , 2019, Journal of Orthopaedic Surgery and Research.
[8] A. Loroño,et al. DAIR (Debridement, Antibiotics and Implant Retention) less effective in hematogenous total knee arthroplasty infections , 2019, Journal of Orthopaedic Surgery and Research.
[9] K. Gromov,et al. Acceptable Success Rate in Patients With Periprosthetic Knee Joint Infection Treated With Debridement, Antibiotics, and Implant Retention. , 2019, The Journal of arthroplasty.
[10] Á. Soriano,et al. Hip and Knee Section, Treatment, Debridement and Retention of Implant: Proceedings of International Consensus on Orthopedic Infections. , 2019, The Journal of arthroplasty.
[11] R. Poolman,et al. Hip and Knee Section, Treatment, Algorithm: Proceedings of International Consensus on Orthopedic Infections. , 2019, The Journal of arthroplasty.
[12] J. Callaghan,et al. Introduction: Proceedings of International Consensus on Orthopedic Infections. , 2019, The Journal of arthroplasty.
[13] K. Huotari,et al. High Cure Rate for Acute Streptococcal Prosthetic Joint Infections Treated With Debridement, Antimicrobials, and Implant Retention in a Specialized Tertiary Care Center , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] M. Whitehouse,et al. Debridement, antibiotics and implant retention for periprosthetic joint infections: A systematic review and meta-analysis of treatment outcomes. , 2018, The Journal of infection.
[15] A. Simpson,et al. Outcomes following debridement, antibiotics and implant retention in the management of periprosthetic infections of the hip: A REVIEW OF COHORT STUDIES , 2017, The bone & joint journal.
[16] A. Hanssen,et al. Predictive value of inflammatory markers for irrigation and debridement of acute TKA infection. , 2013, Orthopedics.
[17] J. Parvizi,et al. Success After Treatment of Periprosthetic Joint Infection: A Delphi-based International Multidisciplinary Consensus , 2013, Clinical orthopaedics and related research.
[18] P. Choong,et al. Cost analysis of debridement and retention for management of prosthetic joint infection. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[19] A. Hanssen,et al. Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] A. Hanssen,et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] Heather N. Watson,et al. Economic burden of periprosthetic joint infection in the United States. , 2012, The Journal of arthroplasty.
[22] G. Euba,et al. Acute haematogenous prosthetic joint infection: prospective evaluation of medical and surgical management. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[23] P. Bejon,et al. Two-stage revision for prosthetic joint infection: predictors of outcome and the role of reimplantation microbiology , 2010, The Journal of antimicrobial chemotherapy.
[24] Daniel Berry,et al. Prosthetic Joint Infection Risk after TKA in the Medicare Population , 2010, Clinical orthopaedics and related research.
[25] S. Kurtz,et al. Prosthetic joint infection risk after total hip arthroplasty in the Medicare population. , 2009, The Journal of arthroplasty.
[26] P. Bejon,et al. One hundred and twelve infected arthroplasties treated with ‘DAIR’ (debridement, antibiotics and implant retention): antibiotic duration and outcome , 2009, Journal of Antimicrobial Chemotherapy.
[27] P E Ochsner,et al. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. , 1998, JAMA.